Case Report: Atypical pediatric allergic bronchopulmonary aspergillosis masquerading as recurrent pneumonia
By
Jingjing Ying
Jin Chen
Danhong Fei
Yongjun Dai
Cheng Zheng
May 18, 2026
Clinical Scorecard: Uncommon Presentation of Pediatric Allergic Bronchopulmonary Aspergillosis Simulating Recurrent Pneumonia: A Case Study
At a Glance
Category Detail
Condition
Key Mechanisms
Target Population Pediatric patients with difficult-to-treat asthma, often misdiagnosed as pneumonia
Care Setting
Key Highlights
Consider ABPA in differential diagnosis for children with recurrent respiratory infections
Guideline-Based Recommendations
Diagnosis
Aspergillus fumigatus-specific IgE ≥ 0.35 kUA/L Total serum IgE ≥ 500 IU/mL Pulmonary infiltrates on imaging consistent with ABPA
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Combination therapy with itraconazole (specific dosage) and corticosteroids effective in managing ABPA
Clinical Best Practices
Educate healthcare providers on the importance of recognizing ABPA in pediatric patients
Related Resources & Content